Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Sep 20;215(6):280-285.
doi: 10.5694/mja2.51218. Epub 2021 Aug 11.

Interventional bronchoscopy for chronic obstructive pulmonary disease: more than a pipe dream

Affiliations
Review

Interventional bronchoscopy for chronic obstructive pulmonary disease: more than a pipe dream

Alan M Carew et al. Med J Aust. .

Abstract

Endoscopic lung volume reduction (ELVR) is recognised in both national and international expert guidelines as one of the few additive treatments to benefit patients with advanced chronic obstructive pulmonary disease (COPD) who are otherwise receiving optimal medical and supportive care. Despite these recommendations and a growing evidence base, these procedures are not widely offered across Australia and New Zealand, and general practitioner and physician awareness of this therapy can be improved. ELVR aims to mitigate the impact of hyperinflation and gas trapping on dyspnoea and exercise intolerance in COPD. Effective ELVR is of proven benefit in improving symptoms, quality of life, lung function and survival. Several endoscopic techniques to achieve ELVR have been developed, with endobronchial valve placement to collapse a single lobe being the most widely studied and commonly practised. This review describes the physiological rationale underpinning lung volume reduction, highlights the challenges of patient selection, and provides an overview of the evidence for current and investigational endoscopic interventions for COPD.

Keywords: Chronic obstructive pulmonary disease; Endoscopy; Lung diseases; Respiration disorders; Respiratory system.

PubMed Disclaimer

References

    1. Australian Institute of Health and Welfare. Deaths in Australia (AIHW Cat. No. PHE 229). Canberra: AIHW, 2019. https://www.aihw.gov.au/reports/life-expectancy-death/deaths-in-australia (viewed July 2020).
    1. Access Economics. Economic impact of COPD and cost effective solutions. Sydney: Access Economics, 2008. http://www.rnig.org.au/docs/EconomicImpactofCOPDandCostEffectiveSolution... (viewed Jul 2020).
    1. Yang IA, Brown JL, George J, et al. The COPD-X Plan: Australian and New Zealand guidelines for the management of chronic obstructive pulmonary disease 2020. Brisbane: Lung Foundation Australia, 2020. https://copdx.org.au/wp-content/uploads/2020/04/COPDX-V2-61-Feb-2020-FIN... (viewed Aug 2020).
    1. Herath SC, Normansell R, Maisey S, Poole P. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD). Cochrane Database Syst Rev 2018; (10): CD009764.
    1. Medical Research Council Working Party. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1981; 1: 681-686.

MeSH terms

LinkOut - more resources